Literature DB >> 30024490

Risk factors for anastomotic recurrence after primary ileocaecal resection in Crohn's disease.

Gisele Aaltonen1, Ilona Keränen, Monika Carpelan-Holmström, Anna Lepistö.   

Abstract

OBJECTIVE: Ileocaecal resection is the most common operation performed in Crohn's disease. Our study aimed to identify the risk factors for anastomotic recurrence following primary ileocaecal resection. PATIENTS AND METHODS: We retrospectively analysed data from all Crohn's disease surgical patients in a single colorectal unit between 2006 and 2016, including all patients who underwent primary ileocaecal resection. We defined anastomotic recurrence as the postoperative need for endoscopic dilatation of the ileocolic anastomosis or neoterminal ileal resection, and used Cox regression to determine the risk factors for such recurrence.
RESULTS: In total, 101 patients underwent primary ileocaecal resection during the study period. Nine (8.9%) patients were excluded because of follow-up less than 1 year and 12 (13.0%) patients had anastomotic recurrence. The median follow-up was 4.7 (1.3-10.8) years. At 3 years, 93.1% of patients required no neoterminal ileal resection or dilatation of the ileocolic anastomosis. Urgent primary ileocaecal resection [hazard ratio (HR)=4.98, 95% confidence interval (CI)=1.45-17.11, P=0.011], stapled anastomosis (HR=20.34, 95% CI=5.06-81.77, P<0.001) and need for postoperative corticosteroid treatment after the primary ileocaecal resection (HR=3.58, 95% CI=1.03-12.40, P=0.044) emerged as significant risk factors for anastomotic recurrence.
CONCLUSION: Urgent surgery and postoperative corticosteroid need represented risk factors for anastomotic recurrence. Hand-sewn anastomosis with an opening of the bowel's antimesenteric border seems to be a safe choice for ileocaecal resection.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30024490     DOI: 10.1097/MEG.0000000000001206

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

Review 1.  Therapeutic strategies in Crohn's disease in an emergency surgical setting.

Authors:  Maria Michela Chiarello; Gilda Pepe; Valeria Fico; Valentina Bianchi; Giuseppe Tropeano; Gaia Altieri; Giuseppe Brisinda
Journal:  World J Gastroenterol       Date:  2022-05-14       Impact factor: 5.374

2.  Ileocolonic End-to-End Anastomoses in Crohn's Disease Increase the Risk of Early Post-operative Endoscopic Recurrence in Those Undergoing an Emergency Resection.

Authors:  Lena W Y Thin; Sherman Picardo; Shanela Sooben; Kevin Murray; Jennifer Ryan; Marina H Wallace
Journal:  J Gastrointest Surg       Date:  2020-05-06       Impact factor: 3.452

Review 3.  Pathophysiology of Crohn's disease inflammation and recurrence.

Authors:  L Petagna; A Antonelli; C Ganini; V Bellato; M Campanelli; A Divizia; C Efrati; M Franceschilli; A M Guida; S Ingallinella; F Montagnese; B Sensi; L Siragusa; G S Sica
Journal:  Biol Direct       Date:  2020-11-07       Impact factor: 4.540

4.  Perforating and nonperforating indications in repeated surgeries for Crohn's disease.

Authors:  Wei-Song Shen; Xiao-Hui Huang; Rui-Qing Liu; Chen-Yang Li; Yi Li; Wei-Ming Zhu
Journal:  World J Clin Cases       Date:  2022-03-26       Impact factor: 1.337

5.  Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysis.

Authors:  Sarah Kneißl; Johannes Stallhofer; Peter Schlattmann; Andreas Stallmach
Journal:  Int J Colorectal Dis       Date:  2022-09-23       Impact factor: 2.796

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.